Georgia Institute of Technology-Main Campus · ChemistryThe Immune Nexus Lab
M.G. Finn · Atlanta, Georgia
Research Focus
Dr. M.G. Finn's research lab at the Georgia Institute of Technology focuses on developing innovative HIV vaccines that utilize controlled delivery systems to enhance immune responses. By incorporating advanced materials and strategies, such as injectable hydrogels and multivalent vaccine platforms, the lab aims to increase the longevity and efficacy of vaccine-induced immunity. Their research not only concentrates on vaccine formulation but also investigates how these vaccines work on a cellular and molecular level in various animal models.
HIV vaccineimmunologycontrolled deliveryvaccine technologymultivalent antigens
Research Aims
5AIM 01Develop sustained release vaccine delivery systems to enhance immune responses.
AIM 02Design multivalent HIV vaccines that promote affinity maturation of B cells.
AIM 03Investigate the mechanisms of vaccine-induced immunity in rodent and non-human primate models.
AIM 04Optimize vaccine formulations for broad and long-lasting protection against HIV-1.
AIM 05Analyze cellular and molecular responses to vaccine immunogens.
Skills the Lab Values
hydrogel formulationvaccine developmentanimal modelsimmunological analysisprotein engineering
Output against the department
Publications505top 18% of dept.38th of 216
this lab
most publishedleast published
Citations55ktop 6% of dept.14th of 216
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.